-
Higher C-peptide levels may identify lower risk for hypoglycemia …
A C-peptide level of more than 20 pmol/L may indicate a lower risk for hypoglycemia among adults with type 1 diabetes, suggesting that these individuals may safely pursue tighter glycemic targets, according to findings published in Diabetic Medicine. “Findings from [the Diabetes Control and Complications Trial] highlight that the benefit…
-
Nighttime insulin requirements greater for young children vs. teens, adults
Children with type 1 diabetes have a greater range of insulin requirements, particularly at night, compared with adolescents and adults with the condition, according to a study of hybrid closed-loop insulin delivery system users. “[This research] helps to understand the challenges parents/guardians have to cope with when managing diabetes of…
-
Just 5% of women with type 1 diabetes receive preconception counseling
NASHVILLE, Tenn. — Only about one in 20 women with type 1 diabetes received preconception counseling, according to data presented at the American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting. Elizabeth Disney, MD, of the University of Utah Hospital and colleagues reviewed records of 541 women from a…
-
Transition Support Program May Aid Young Adults With Type 1 Diabetes
MONDAY, April 29, 2019 (HealthDay News) — Structured support for patients transitioning from pediatric to adult care for type 1 diabetes may improve outcomes, but those benefits are not sustained after completion of the intervention, according to a study published online April 22 in Diabetes Care. Tamara Spaic, M.D., from…
-
Higher HbA1c, daily insulin injections increase diabetic ketoacidosis risk
LOS ANGELES — Adults with type 1 diabetes and HbA1c levels of at least 9% are more likely to develop diabetic ketoacidosis, or DKA, than those who reach lower targets, according to findings presented at AACE Annual Scientific and Clinical Congress. “Achieving glycemic control remains a major barrier to the…
-
Dapagliflozin Improves Glucose Outcomes in Type 1 Diabetes
FRIDAY, April 26, 2019 (HealthDay News) — In patients with type 1 diabetes, treatment with dapagliflozin for 24 weeks improves time in range, mean glucose, and glycemic variability, according to a study published online April 9 in Diabetes Care. Chantal Mathieu, M.D., PhD., from the University of Leuven in Belgium,…
-
Home-Based Video Visits Useful for Pediatric Patients With Poorly Controlled Type 1 Diabetes
Pediatric patients with poorly controlled type 1 diabetes (T1D) consider home-based video visits with healthcare providers to be feasible and satisfactory, according to study results published in the Journal of Telemedicine and Telecare. To evaluate the feasibility of home-based video visits for pediatric patients with T1D who might benefit from…
-
Future iPhone, Apple Watch sensors could detect low blood sugar based on body odor alone
Hazardous gases in the air are extremely difficult for humans to detect until it is typically too late, such as with carbon monoxide, a common gas known for being potentially lethal. Short of using a device that can monitor the air nearby, the person simply won’t know there is an…
-
Wearable Device for Heart Rate Variability Can Detect Early Hypoglycemia
A wearable device that measures real-time heart rate variability can detect early signs of hypoglycemia in patients with type 1 diabetes, according to study results published in Diabetes Care. To assess the ability of a wearable device to detect heart rate variability and alert users to early signs of hypoglycemia…
-
Recurrent hypoglycemia more frequent with lower initial blood glucose
NEW ORLEANS — Lower blood glucose levels and treatment with non-oral glucose medications before receiving emergency medical services, or EMS, during an episode of hypoglycemia may result in additional need for EMS, according to findings presented at the Endocrine Society Annual Meeting. “Many EMS systems are adopting treat-and-release protocols designed…
